Great Point Partners 13F filings
Manager(s): Dr. Jeffrey Jay, M.D. and Mr. David Kroin
Holdings as of 2024-09-30
Filed on 2024-11-13 under CIK 1281446
Company
Investment Type
Change
Value (x$1000)
increase or decrease
NEUROGENE INC COM
1,004,291 sh
$42,140
Abivax SA F Sponsored ADR Stock
2,128,773 sh
-343,415 sh
-14%
-14%
$24,523
-$8,159
Pliant Therapeutics Inc. COM
1,910,121 sh
-726,743 sh
-28%
-28%
$21,412
-$6,934
EVOLUS INC COM
1,170,000 sh
-1,281,772 sh
-52%
-52%
$18,954
-$7,648
VIRIDIAN THERAPEUTICS Common Stock
750,000 sh
250,000 sh
50%
50%
$17,063
$10,558
CYTOKINETICS INC COM NEW
316,000 sh
-158,202 sh
-33%
-33%
$16,685
-$9,007
KALVISTA PHARMACEUTICALS INC COM
1,299,503 sh
-39,065 sh
-3%
-3%
$15,048
-$720
CONTEXT THERAPEUTICS INC COM COM
6,934,982 sh
-484,373 sh
-7%
-7%
$13,593
-$1,283
ZURA BIO LTD CLASS A ORD SHS
3,263,672 sh
-1,378,569 sh
-30%
-30%
$13,251
-$2,997
ORUKA THERAPEUTICS INC COM
514,659 sh
514,659 sh
NEW
NEW
$12,614
$12,614
MERUS N V COM
250,000 sh
-273,288 sh
-52%
-52%
$12,490
-$18,473
Olema Pharmaceuticals Inc. COM
1,000,000 sh
203,120 sh
25%
25%
$11,940
$3,318
AUTOLUS THERAPEUTICS PLC SPON ADS
2,811,955 sh
-629,712 sh
-18%
-18%
$10,207
-$1,770
UroGen Pharma Ltd. COM
758,786 sh
-2,147,473 sh
-74%
-74%
$9,637
-$39,130
DIANTHUS THERAPEUTICS INC COM
275,000 sh
-482,929 sh
-64%
-64%
$7,530
-$12,085
OUTLOOK THERAPEUTICS INC COM Common Stock
1,293,028 sh
-408,482 sh
-24%
-24%
$6,905
-$5,652
JASPER THERAPEURITC, INC. Stock
322,380 sh
-79,635 sh
-20%
-20%
$6,064
-$3,062
Voyager Therapeutics Inc COM
959,953 sh
-641,574 sh
-40%
-40%
$5,616
-$7,052
HELIX ACQUISITION CORP II CL A ORD SHS
500,000 sh
$5,225
Unicycive Therapeutics Inc. COM
8,559,000 sh
8,559,000 sh
NEW
NEW
$3,491
$3,491
ProMIS Neurosciences Inc COM
2,790,698 sh
2,790,698 sh
NEW
NEW
$3,488
$3,488
CARTESIAN THERAPEUTICS INC COM NEW Stock
200,000 sh
200,000 sh
NEW
NEW
$3,224
$3,224
VISTAGEN THERAPEUTICS ORD COM
674,075 sh
-855,263 sh
-56%
-56%
$2,029
-$3,293
Eliem Therapeutics Inc. COM
248,168 sh
248,168 sh
NEW
NEW
$1,263
$1,263
INSMED INC COM PAR $.01
0 sh
-250,000 sh
-100%
-100%
$0
-$16,750
Esperion Therapeutics Inc COM
0 sh
-5,791,594 sh
-100%
-100%
$0
-$12,857
Terns Pharmaceuticals Inc. COM
0 sh
-1,149,406 sh
-100%
-100%
$0
-$7,827
PUMA BIOTECHNOLOGY INC COM
0 sh
-1,486,544 sh
-100%
-100%
$0
-$4,846
Kyverna Therapeutics, Inc. Common Stock
0 sh
-499,152 sh
-100%
-100%
$0
-$3,744
AEGLEA BIOTHERAPEUTICS INC cs
0 sh
-134,612 sh
-100%
-100%
$0
-$3,165
Lexicon Pharmaceuticals Inc COM NEW
0 sh
-30,000 sh
-100%
-100%
$0
-$50